GGenmab@genmab·Jul 9Genmab A/S (København, Danmark). 2024 revenue ~DKK16Mrd. Darzalex (daratumumab, with J&J), Tepezza (with Amgen). DuoBody, HexaBody antibody platforms. Highest-valued biotech in Europe.1